PursueCare Relaunches RESET and RESET-O Digital Therapeutics for Substance Use Disorders

PursueCare, a leader in virtual addiction treatment, has reintroduced the prescription digital therapeutics (PDTs) RESET and RESET-O, designed for patients with substance use disorder and opioid use disorder, respectively. Originally developed by Pear Therapeutics, the RESET platforms provide a 12-week, self-guided cognitive behavioral therapy (CBT) program aimed at incentivizing patients to follow their treatment plans and reduce drug use. PursueCare acquired these assets after Pear filed for Chapter 11 bankruptcy last year.

RESET and RESET-O are integrated with PursueCare’s broader virtual care services, allowing for continuous support and personalized progress tracking for patients. By partnering with health plans, PursueCare is aligning these tools with value-based care models to increase patient engagement and support cost-effective, outcome-focused treatment.